Page last updated: 2024-11-05

3-bromobenzanthrone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

3-Bromobenzanthrone is a synthetic organic compound that is a brominated derivative of benzanthrone. It is a yellow solid that is sparingly soluble in most organic solvents. The compound is synthesized through a multi-step process that involves bromination of benzanthrone. 3-Bromobenzanthrone is a potential precursor to other important organic compounds, including dyes and pharmaceuticals. It has been studied for its potential biological activity and its role in various chemical reactions. The compound has been investigated for its antimicrobial and anti-inflammatory properties, but further research is needed to fully understand its potential applications.'
```

Cross-References

ID SourceID
PubMed CID6696
SCHEMBL ID1983882
MeSH IDM0454688

Synonyms (49)

Synonym
3-bromobenz(de)anthracen-7-one
brn 1975512
nsc 13976
3-bromobenz(d,e)anthrone
7h-benz(de)anthracen-7-one, 3-bromo-
einecs 201-390-7
3-bromo-7h-benz(de)anthracen-7-one
3-bromo-7h-benz[de]anthracen-7-one
3-bromobenz[d,e]anthrone
7-bromomesobenzanthrone
3-brombenzanthrone
3-bromobenzanthrone ,
nsc13976
benzanthrone, 3-bromo-
81-96-9
nsc-13976
wln: l c6666 1a q ivj oe
7h-benz[de]anthracen-7-one, 3-bromo-
EU-0000135
AC-11850
3-bromobenzo[b]phenalen-7-one
AKOS001073212
STK801556
3-bromo-7h-benzo[de]anthracen-7-one
A840227
3-bromo-7h-benz[de]anthracene-7-one
BBL010353
3dh9916fno ,
4-07-00-01820 (beilstein handbook reference)
unii-3dh9916fno
F0266-1973
FT-0615196
7h-benz[de]anthracen-7-one,3-bromo-
SCHEMBL1983882
DTXSID9058860
3-bromo-benzanthrone
W-104192
AE-641/00609011
3-bromobenz[de]anthrone
7h-benz[de]anthracene-7-one, 3-bromo-
mfcd00021094
sr-01000389293
SR-01000389293-1
Z56886929
3-bromo benzanthrone
DS-3440
D97803
EN300-235659
14-bromotetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,9,11,13,15-octaen-8-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.55 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]